Humana Trims Its 2027 Advantage Menu, Letters Land in October

Humana is cutting Medicare Advantage plans for the 2027 plan year and will send non-renewal letters to affected members in early October, a notice that triggers a federal guaranteed-issue protection many long-time Advantage members do not know they still hold.

Humana is pulling Medicare Advantage plans out of its 2027 lineup, and the members affected will find out the way they always do: by mail. Non-renewal letters are scheduled to reach households in early October, just before the annual election period opens and the flood of plan marketing begins.

For the recipient, the letter reads like a rejection. Functionally, it is closer to a coupon. Federal Medicare rules attach a protection to an involuntary plan termination that a member who simply switched plans on their own would not get — and, as 24/7 Wall St notes, most long-time Advantage members have no idea they still qualify for it.

Why a non-renewal letter is not the same as a plan change

Medicare Advantage is the private alternative to original Medicare: an insurer contracts with the federal government to deliver Part A and Part B benefits, usually bundles in drug coverage, and manages the care through a network. Those contracts are renegotiated county by county, year by year. When the arithmetic in a given county stops working — reimbursement, network economics, utilization — the insurer can decline to renew there. The plan disappears for everyone in it, regardless of how healthy or how loyal the member is.

That involuntary quality is the whole point. Under federal rules, a member whose plan is terminated is not treated as a shopper. They are treated as someone whose coverage was taken away, and that status carries a guaranteed-issue right to buy certain Medigap policies — the supplemental insurance that sits alongside original Medicare and pays the deductibles, copays and coinsurance that Medicare itself leaves on the table.

Guaranteed issue means the Medigap carrier cannot refuse the application, cannot impose a waiting period for a pre-existing condition, and cannot price the policy higher because of health history. Outside a protected window, Medigap in most states is medically underwritten: an applicant with a serious diagnosis can be declined outright. That is precisely why members who have been in Advantage plans for a decade or more often assume the door to supplemental coverage is permanently shut. A non-renewal letter reopens it, but only for a limited period tied to the end of coverage.

What the letter actually asks the member to decide

An affected Humana member has three broad paths, and the October timing means the decision has to be made while the same mailbox is filling with brochures from every competing insurer in the county.

• Move to another Medicare Advantage plan. The simplest option, and the one the marketing is designed to produce. It preserves the low-or-zero premium structure and the extras, but it keeps the member inside a network and outside the guaranteed-issue Medigap window, which lapses unused.
• Return to original Medicare and add a Medigap policy. This is the path the federal protection is built for. Premiums are higher and predictable; the network restrictions vanish. Crucially, the member also needs a standalone Part D drug plan, because Medigap does not cover prescriptions.
• Return to original Medicare with no supplement. The cheapest monthly outlay and the largest exposure, since original Medicare has no annual out-of-pocket ceiling.

The asymmetry matters. Choosing another Advantage plan is reversible in a loose sense — there is another election period every year. Letting the guaranteed-issue window close is not reversible for anyone whose health record would fail underwriting. Members with a cancer history, advanced heart or kidney disease, or a recent major procedure are exactly the group for whom the letter is most valuable and most likely to be misread as bad news.

Which plans, and which counties, remains the open question

Neither the number of plans being retired nor the counties involved has been laid out in the material available so far. Members will learn their own answer from the letter itself, and brokers will assemble the map once the 2027 plan files become public. Anyone who wants to get ahead of it should watch for two things: whether the non-renewal covers the whole contract in a county or only specific plan benefit packages, and whether Humana is offering a crosswalk into a replacement plan, which changes the practical default for members who do nothing.

What this fits into is a broader repricing of Medicare Advantage across the industry. Insurers spent years expanding county footprints and stacking on supplemental benefits; the recent direction of travel has been the opposite — trimming geographies and thinning benefit packages to defend margins rather than chase enrollment. A non-renewal is the bluntest version of that discipline. It sheds the membership an insurer believes it cannot cover profitably, and it does so without the slow grind of benefit cuts.

The trade-off for shareholders

Humana (HUM) shares last traded at 385.54, down 1.81% from the prior close of 392.63, in a session that ranged between 385.22 and 397.33 — the stock finished at the low end of its range as of the last trade on Friday, 28 August 2026. That was a weaker showing than the broad tape: the S&P 500 proxy SPY closed at $769.35, off 0.23%, the Dow tracker DIA was essentially flat at $535.06, and the Nasdaq 100 fund QQQ closed at $716.43, down 0.65%. In point terms, Humana's decline worked out to roughly 7.09 on the day, an illustrative figure derived from the closing and prior-close prices above.

Exiting plans is a margin decision before it is a growth decision. Shrinking a footprint mechanically lowers membership and the premium revenue attached to it, while lifting the average quality of what remains — the members and counties where the medical loss ratio, the share of premium paid out in claims, is defensible. Investors generally reward that trade when they believe the alternative was another year of adverse claims experience, and punish it when it looks like an insurer losing ground it cannot get back.

The signal to watch is not the count of retired plans on its own. It is the pairing: how much enrollment goes out the door, and what the company says about the cost trend in the book it kept.

A short calendar for anyone holding a letter

Early October brings the notices. The annual election period follows, and it is the window in which an Advantage-to-Advantage switch is made. Running in parallel — and this is the part that gets lost — is the guaranteed-issue Medigap window created by the termination itself, which is defined by the end of the plan's coverage rather than by the election period calendar. Members who intend to use it should price Medigap policies and a standalone Part D plan before they respond to any Advantage marketing, and should keep the non-renewal letter, because Medigap carriers require it as proof of the right.

Practical order of operations: confirm in writing when coverage actually ends, get the Medigap quotes for your zip code, check whether your physicians and prescriptions survive under each option, then decide. The costly mistake is not picking the wrong plan. It is discovering in 2028 that the one option requiring no health questions expired months earlier.

Key facts

• Ticker (last close): HUM — 385.54, -1.81%, as of Fri, 28 Aug 2026 20:00 GMT
• What is changing: Humana is cutting Medicare Advantage plans for the 2027 plan year
• Notice timing: Non-renewal letters arrive in early October
• Member protection: Federal rules grant a guaranteed-issue Medigap right after an involuntary plan termination

Frequently asked questions

What does a Humana non-renewal letter mean?

It means the specific Medicare Advantage plan you are enrolled in will not be offered in your area for the 2027 plan year. The plan ends for every member in it, regardless of health status or how long you have been enrolled. Humana is scheduled to mail these notices in early October, ahead of the annual election period.

What is the guaranteed-issue Medigap right?

Guaranteed issue means a Medigap carrier must sell you certain supplemental policies without medical underwriting. It cannot decline your application, charge more because of your health history, or impose a pre-existing-condition waiting period. Federal Medicare rules attach this right to an involuntary plan termination, which is why a non-renewal letter is worth keeping as proof.

Why can't long-time Advantage members normally buy Medigap?

Outside a protected window, Medigap in most states is medically underwritten. An applicant with a serious diagnosis can be refused or priced up sharply. Members who have spent years in Medicare Advantage often assume they are locked out permanently. An involuntary non-renewal temporarily removes the health screening for eligible policies.

Does Medigap cover prescription drugs?

No. Medigap policies pay the deductibles, copayments and coinsurance left by original Medicare, but they do not include prescription coverage. A member returning to original Medicare with a Medigap policy generally needs to add a standalone Part D drug plan separately, and should compare drug formularies before committing to either piece.

How many Humana plans and counties are affected?

The number of retired plans and the specific counties involved have not been detailed in the information released so far. Affected members will learn their own status from the letter itself, and the full picture typically becomes clear once the 2027 plan filings are public and brokers map the changes county by county.

How did Humana stock perform most recently?

Humana shares last traded at 385.54, down 1.81% from a prior close of 392.63, with a session range of 385.22 to 397.33, as of the last trade on Friday, 28 August 2026. That trailed the broad market that session: SPY closed at $769.35 (-0.23%), DIA at $535.06 (-0.03%) and QQQ at $716.43 (-0.65%).

Sources

• Humana Is Cutting Medicare Advantage Plans for 2027. The Non-Renewal Letters Arrive in Early October. — 24/7 Wall St

Photo: RDNE Stock project · Pexels Licence — source